"I contend if Alzheimer's is bad, ignorance of the disease is worse," said former Wisconsin Gov. Marty Schreiber, who understands the disease all too well.

When Paul Cotter's father began to show signs of early-onset Alzheimer's disease, he lost job after job. Then a small local ...

Axsome Therapeutics (NASDAQ:AXSM) said on Monday that in the FDA meeting minutes, the agency has supported a supplemental NDA ...

The lifetime risk of dementia after age 55 is about 42%, according to a recent study published in the journal Nature Medicine. Around 1 million adults in the U.S. are projected to develop dementia ...

The research team, coordinated by pharma startup Cortexyme, did not claim to have discovered definitive evidence of Alzheimer ...

A blood test that detects the biological age of organs can predict the risk of health conditions many years in advance, ...

Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.

Doctors are constantly seeking clues to help diagnose Alzheimer’s disease and researchers at the Indiana University School of ...

Axsome Therapeutics (AXSM) has received formal pre-New Drug Application meeting minutes from the U.S. Food and Drug Administration supporting a ...

A recent perspective offered guidance to clinician’s in managing how or in some cases whether to disclose a diagnosis of ...

Herpesvirus infection may contribute to Alzheimer’s disease through transposable element activation and neuroinflammation.

Health equity ensures that everyone -- regardless of race, income or geographic location -- has an equal opportunity to achieve optimal health, writes guest columnist the Rev. Frederick Knuckles Sr.